What is Angio Systems?
Angio Systems operates as a critical infrastructure provider within the global healthcare supply chain, specializing in high-precision medical innovations. With a legacy spanning over four decades, the firm has established itself as a primary manufacturer of essential procedural tools, including radiation protection shields, surgical drapes, and specialized access sleeves. Their product portfolio, which features the flagship SorbX radiation shield, is engineered to address the rigorous safety and efficiency requirements of Cardiac Cath Labs and Interventional Radiology departments. By focusing on custom-tailored solutions, Angio Systems effectively mitigates procedural complications while enhancing patient outcomes, maintaining a competitive edge through deep technical expertise and long-standing institutional partnerships with leading hospitals worldwide.
How much funding has Angio Systems raised?
Angio Systems has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Angio Systems
PPP
Public-Private Partnership
What's next for Angio Systems?
With the successful acquisition of this latest capital, Angio Systems is well-positioned to accelerate its operational growth and expand its footprint in the medical device market. The strategic allocation of these funds will likely prioritize the optimization of manufacturing workflows and the potential development of next-generation procedural safety equipment. As the company transitions through this late-stage growth phase, the focus will remain on maintaining its reputation for quality while scaling its distribution network to meet the increasing demand for specialized interventional tools. Investors and industry stakeholders will be monitoring how this infusion of resources translates into broader market penetration and the continued evolution of their core product lines in an increasingly complex regulatory and clinical environment.
See full Angio Systems company page
